TAB-012-F(E)

antibody from Creative Biolabs

Targeting: VEGFA VEGF, VEGF-A, VPF

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Blocking/Neutralizing (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

TAB-012-F(E)

Provider

Creative Biolabs

Product name

Anti-Human VEGF Recombinant Antibody Fab Fragment (Ranibizumab)

Antibody type

Monoclonal

Description

Recombinant monoclonal antibody Fragment Fab to Human VEGF. Ranibizumab (trade name ranibizumab) is a monoclonal antibody fragment (Fab) derived from the same parent mouse antibody as bevacizumab (bevacizumab). It is much smaller than the parent molecule and has been affinity matured to provide stronger binding to VEGF-A. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.

Reactivity

Human

Host

Mouse

Storage

Store at 4¡ãC for up to 3 months. For longer term storage aliquot into small volumes and store at -20¡ãC.